Related Experiment Video
Updated: Feb 25, 2026

Murine Kidney Transplant Technique
Published on: October 20, 2015
Vascular Damage and Kidney Transplant Outcomes: An Unfriendly and Harmful Link
Domingo Hernández1, Javier Triñanes2, Ana María Armas3
1Nephrology Department, Carlos Haya Regional University Hospital, University of Malaga, IBIMA, REDinREN, Málaga, Spain.
Insights
Kidney transplant recipients face high cardiovascular mortality from vascular issues like calcification and atherosclerosis. Understanding these vascular lesions and their causes is key to improving patient outcomes and survival.
Area of Science:
- Nephrology and Cardiovascular Medicine
- Transplantation Science
- Vascular Biology and Pathology
Background:
- Kidney transplantation (KT) is optimal for chronic kidney disease but associated with high cardiovascular mortality.
- Traditional and nontraditional risk factors, including vascular calcification, contribute to adverse cardiovascular events post-KT.
- Inflammation, mineral metabolism disorders, and renin-angiotensin system activation are implicated in vascular damage in KT recipients.
Purpose of the Study:
- To review epidemiological data on cardiovascular complications in kidney transplant recipients.
- To analyze atheromatosis, arteriosclerosis, and vascular calcifications in KT patients.
- To explore pathogenic mechanisms and potential therapeutic targets for vascular damage in this population.
Main Methods:
- This is a review article, synthesizing existing epidemiological data and research findings.
- Focuses on analyzing subclinical and clinical atheromatosis, including ischemic heart disease, heart failure, stroke, and peripheral vascular disease.
- Examines arteriosclerosis and vascular calcifications, discussing underlying pathogenic mechanisms and therapeutic strategies.
Main Results:
- Kidney transplant recipients exhibit significant rates of atheromatosis and arteriosclerosis, contributing to high cardiovascular mortality.
- Vascular calcification is a prominent feature, linked to mineral metabolism disturbances and inflammation.
- Multiple pathogenic pathways, including inflammation and renin-angiotensin system activation, are involved in vascular lesion development.
Conclusions:
- Understanding the complex vascular lesions and pathogenic mechanisms in KT recipients is critical.
- Targeting these mechanisms may optimize therapeutic management and improve long-term survival.
- Further research into novel therapeutic targets is warranted to mitigate cardiovascular risk post-transplantation.
Abstract:
Kidney transplant (KT) is the treatment of choice for most patients with chronic kidney disease, but this has a high cardiovascular mortality due to traditional and nontraditional risk factors, including vascular calcification. Inflammation could precede the appearance of artery wall lesions, leading to arteriosclerosis and clinical and subclinical atherosclerosis in these patients. Additionally, mineral metabolism disorders and activation of the renin-angiotensin system could contribute to this vascular damage. Thus, understanding the vascular lesions that occur in KT recipients and the pathogenic mechanisms involved in their development could be crucial to optimize the therapeutic management and outcomes in survival of this population. This review focuses on the following issues: (1) epidemiological data framing the problem; (2) atheromatosis in KT patients: subclinical and clinical atheromatosis, involving ischemic heart disease, congestive heart failure, stroke and peripheral vascular disease; (3) arteriosclerosis and vascular calcifications; and (4) potential pathogenic mechanisms and their therapeutic targets.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Acute Kidney Injury II: Pathophysiology

